NCNMGF
BIOA

Nano-Cap New Millennium Growth Fund’s BioAge Labs BIOA Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,000
Closed -$1.06M – 183
2025
Q4 		$1.06M Buy
+80,000
New +$709K 0.9% 38

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's BIOA Position: Q1 2026 in Review

Nano-Cap New Millennium Growth Fund sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 80,000 shares — an estimated $1.06M sold.

Nano-Cap New Millennium Growth Fund first reported a position in BIOA in Q4 2025 and held it in 1 quarter. The position peaked at $1.06M in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Nano-Cap New Millennium Growth Fund reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Nano-Cap New Millennium Growth Fund sold 80,000 BioAge Labs shares in Q1 2026, an estimated $1.06M.
  • Nano-Cap New Millennium Growth Fund first reported a position in BioAge Labs in Q4 2025 and held it in 1 quarter.
  • Nano-Cap New Millennium Growth Fund's BioAge Labs position peaked at $1.06M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q1 2026, filed 15 May 2026.